Related Experiment Video
Updated: Jan 5, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
[Level of circulating Alarin in obese children and its association with insulin resistance]
Man-Qin Li1, Jiao-Yang Li, Li Xie
1Pediatric Intensive Care Unit, First Affiliated Hospital of University of South China, Hengyang, Hunan 421001, China. 7988780@qq.com.
Insights
Obese children show elevated circulating Alarin levels, which correlate with increased body mass index (BMI) and insulin resistance (IR). This suggests Alarin may play a role in the development of childhood obesity and metabolic dysfunction.
Area of Science:
- Pediatric Endocrinology
- Metabolic Research
- Obesity Studies
Background:
- Childhood obesity is a growing global health concern.
- Obesity is frequently associated with metabolic complications, including insulin resistance (IR).
- Identifying biomarkers for obesity and associated metabolic disturbances is crucial for early intervention.
Purpose of the Study:
- To investigate the levels of circulating Alarin in obese children.
- To explore the association between Alarin levels and various metabolic parameters in this population.
Main Methods:
- A case-control study involving 86 obese children and 82 healthy controls.
- Measurement of anthropometric data, blood pressure, and metabolic markers (lipids, glucose, insulin).
- Calculation of indices for insulin resistance (HOMA-IR, WBISI) and assessment of circulating Alarin via ELISA.
Main Results:
- Obese children exhibited significantly higher circulating Alarin levels compared to healthy controls.
- Alarin levels were also elevated in obese children with IR compared to those without IR.
- Circulating Alarin positively correlated with BMI, triglycerides, fasting glucose, and IR markers, and negatively with insulin sensitivity.
Conclusions:
- Circulating Alarin levels are significantly increased in obese children.
- Elevated Alarin may be linked to the pathogenesis of obesity and the development of insulin resistance in children.
Objective:
To study the level of circulating Alarin in obese children and its association with various metabolic parameters.
Methods:
A total of 86 obese children with a body mass index (BMI) above the 95th percentile were enrolled as the obesity group, and 82 healthy children, matched for age and sex, with a BMI below the 85th percentile were enrolled as the healthy control group. According to the presence or absence of insulin resistance (IR), the obesity group was further divided into an IR group with 27 children and a non-IR group with 59 children. Related anthropometric parameters, including body height, body weight, systolic blood pressure (SBP), and diastolic blood pressure (DBP), were measured, and BMI was calculated. Total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), uric acid (UA), fasting insulin (FINS), and fasting blood glucose (FBG) were measured. The area under the receiver operating characteristic curve (AUC) for glucose and insulin, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), and whole-body insulin sensitivity index (WBISI) were calculated. ELISA was used to measure the level of circulating Alarin.
Results:
The obesity group had a significantly higher level of circulating Alarin than the healthy control group (P<0.01). The IR group had a significantly higher level of circulating Alarin than the non-IR group (P<0.01). Circulating Alarin was positively correlated with BMI, TG, FBG, AUC-glucose, AUC-FINS, and HOMA-IR (P<0.05) and was negatively correlated with WBISI (P<0.05). The circulating Alarin level had a linear regression relationship with BMI, FBG, and HOMA-IR, among which HOMA-IR had the greatest influence on the circulating Alarin level (P<0.05).
Conclusions:
There is a significant increase in the circulating Alarin level in obese children, which may be associated with the development of obesity and IR.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin: The Receptor and Signaling Pathways
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug Dosing: Obese Patients

